IP Verse

Stolmar & Partner patent opposition analysis

The comprehensive analysis of Stolmar & Partner opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Stolmar & Partner

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3818027	Particle-Stabilized Foams Using Sustainable Materials	ETH ZURICH	Sep 17, 2025	SWISSPOR MANAGEMENT
EP3960072	Compact On-Body Physiological Monitoring Devices And Methods Thereof	ABBOTT	Sep 10, 2025	STOLMAR MATTHIAS
EP3824139	Method Of Producing A 3D Molded Pulp Product	CELWISE	Sep 4, 2025	STOLMAR MATTHIAS
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 18, 2025	EGIS
EP3626270	New Use	NOVARTIS	Jul 8, 2024	EGIS
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Oct 9, 2023	EGIS
EP2959894	S1P Receptor Modulators For Treating Multiple Sclerosis	NOVARTIS	Jul 11, 2023	EGIS
EP2234617	Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters	JANSSEN PHARMACEUTICA	Dec 31, 2021	EGIS
EP2582754	Tacky Finish And Textile Materials And Articles Treated Therewith	MILLIKEN	Sep 2, 2021	KORDSA TEKNIK TEKSTIL
EP2617807	Culture Substrate	AGC TECHNO GLASS	Jul 21, 2021	STOLMAR & PARTNER PATENTANWALTE PARTG MBB

Top companies who are the clients of Stolmar & Partner

Company	Total
EGIS	6
STOLMAR & PARTNER PATENTANWALTE PARTG MBB	3
STOLMAR MATTHIAS	2
STOLMAR	1
BUHLMANN LABORATORIES	1
SWISSPOR MANAGEMENT	1
KLUBER LUBRICATION MUNCHEN	1
KORDSA TEKNIK TEKSTIL	1